Enanta pharmaceuticals Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Enanta pharmaceuticals Contact Number

About Contact Us, Enanta Pharmaceuticals, Inc

2 hours ago Enanta.com Show details

(617) 607-0800Enanta Pharmaceuticals, Inc. Headquarters 500 Arsenal Street Watertown, MA 02472. Enanta Pharmaceuticals, Inc. 400 Talcott Ave

1. 400 Talcott Ave, Watertown, MA 02472 · (617) 607-0800DIRECTIONSWEBSITE

Category: Contact SupportShow more

Enanta Pharmaceuticals Inc. Better Business Bureau® …

9 hours ago Bbb.org Show details

Enanta Pharmaceuticals Inc. 500 Arsenal St Contact Information. and understand that the nature of complaints and a firm's responses to them are often more important than the number of

Category: Contact NumberShow more

Enanta Pharmaceuticals Crunchbase Company Profile & …

2 hours ago Crunchbase.com Show details

Contact Email [email protected]enanta.com. Phone Number 6176070530. Enanta Pharmaceuticals, Inc., a research and development company, engages in the discovery, development, and promotion of small molecule drugs in the areas of anti-infective. It develops protease, NS5A, polymerase, and cyclophilin-based inhibitors for the treatment of hepatitis C virus (HCV).

Founded: 1998

Category: Contact NumberShow more

Enanta Pharmaceuticals Email Format enanta.com Emails

5 hours ago Rocketreach.co Show details

Enanta Pharmaceuticals Email Format. Enanta Pharmaceuticals uses 8 email formats, with first_initial last (ex. [email protected]enanta.com) being used 41.7% of the time. Get Verified Emails for Enanta Pharmaceuticals Employees. Enanta Pharmaceuticals's Email Format. Percentage.

Category: Contact NumberShow more

Enanta Pharmaceuticals, Inc. Company Profile Watertown

Just Now Dnb.com Show details

Find company research, competitor information, contact details & financial data for Enanta Pharmaceuticals, Inc. of Watertown, MA. Get the latest business insights from Dun & Bradstreet.

Category: Contact NumberShow more

8K

7 hours ago Sec.gov Show details

Exhibit Number. Description. 99.1. Press Release of Enanta Pharmaceuticals, Inc. dated November 22, 2021, reporting Enanta's financial results for the fiscal quarter and year ended September 30, 2021. 104. Cover Page Interactive Data File (embedded within the Inline XBRL document)

Category: Contact NumberShow more

Enanta Pharmaceuticals, inc (ENTA) Q4 2021 Earnings Call

7 hours ago Msn.com Show details

Enanta Pharmaceuticals, inc (ENTA) Q4 2021 Earnings Call Transcript Motley Fool Transcribers 5 days ago Fauci says omicron variant might 'evade immune protection': COVID-19 updates

Category: Contact NumberShow more

Enanta Pharmaceuticals LinkedIn

5 hours ago Linkedin.com Show details

Enanta Pharmaceuticals 6,657 followers on LinkedIn. Creating small molecule drugs for viral infections and liver diseases Enanta Pharmaceuticals is using its …

Category: Contact NumberShow more

Luke Hubbard Associate D.. Enanta Pharmaceuticals

Just Now Zoominfo.com Show details

View Luke Hubbard's business profile as Associate Director at Enanta Pharmaceuticals. Find contact's direct phone number, email address, work history, and more.

Category: Contact NumberShow more

Enanta Pharmaceuticals, inc (ENTA) Q4 2021 Earnings Call

9 hours ago Fool.com Show details

Enanta Pharmaceuticals, inc (ENTA) Q4 2021 Earnings Call Transcript ENTA earnings call for the period ending September 30, 2021.

Category: Contact NumberShow more

Enanta Pharmaceuticals Number of Employees 20112021

9 hours ago Macrotrends.net Show details

Enanta Pharmaceuticals number of employees from 2011 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Enanta Pharmaceuticals, Inc. is a biotechnology company. It engages in the research and development of molecule drugs

Category: Contact NumberShow more

Where Enanta Pharmaceuticals Stands With Analysts

8 hours ago Markets.businessinsider.com Show details

According to 11 analyst offering 12-month price targets in the last 3 months, Enanta Pharmaceuticals has an average price target of $88.27 with a high of $121.00 and a low of $55.00. Below is a

Category: Contact NumberShow more

Understanding Enanta Pharmaceuticals Inc. (NASDAQ: ENTA)’s

9 hours ago Stocksregister.com Show details

Enanta Pharmaceuticals Inc. (NASDAQ:ENTA) shares, rose in value on Friday, 11/05/21, with the stock price up by 11.10% to the previous day’s close as strong demand from buyers drove the stock to $97.37. Actively observing the price movement in the last trading, the stock closed the session at $87.

Category: Contact NumberShow more

Jobs with Enanta Pharmaceuticals, Inc.

9 hours ago Biospace.com Show details

7/29/2021. Enanta Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, announced that it plans to report its financial results for its fiscal third quarter ended June 30, 2021 after the U.S. markets close on August 5, 2021.

Category: Contact NumberShow more

Enanta Pharmaceuticals, Inc., Jobs & Salary for Foreign

3 hours ago Myvisajobs.com Show details

Enanta Pharmaceuticals, Inc. has filed 4 labor condition applications for H1B visa and 0 labor certifications for green card from fiscal year 2018 to 2020. Enanta Pharmaceuticals was ranked 32526 among all visa sponsors. Please note that 0 LCA for H1B Visa and 0 LC for green card have been denied or withdrawn during the same period. Contact (edit)

Category: Contact NumberShow more

Enanta Pharmaceuticals Inc (ENTA) 10K Annual Reports & 10Q

6 hours ago Last10k.com Show details

WATERTOWN, Mass., November 23, 2020 – Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today reported financial results for its fiscal fourth quarter and year ended September 30, 2020. “2020 was marked by significant

Category: Contact NumberShow more

Enanta Pharmaceuticals Announces Update to its Hepatitis B

7 hours ago Us.acrofan.com Show details

Discontinuing Clinical Development of EDP-721, an Oral HBV RNA DestabilizerContinuing to Focus on Development of EDP-514 in Combination Regimens as a Functional Cure for HBVWATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small …

Category: Contact NumberShow more

Analysts Estimate Enanta Pharmaceuticals (ENTA) to Report

6 hours ago Markets.businessinsider.com Show details

So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.For the last reported quarter, it was expected that Enanta Pharmaceuticals would post a loss

Category: Contact NumberShow more

enta8k_20210805.htm

Just Now Sec.gov Show details

Number Description 99.1 Press Release of Enanta Pharmaceuticals, Inc. dated August 5, 2021, reporting Enanta’s financial results for the fiscal quarter ended June 30, 2021 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

Category: Contact NumberShow more

Analysts Estimate Enanta Pharmaceuticals (ENTA) to Report

9 hours ago Zacks.com Show details

Enanta Pharmaceuticals (ENTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get …

Category: Contact NumberShow more

FY2022 Earnings Forecast for Enanta Pharmaceuticals, Inc

3 hours ago Marketbeat.com Show details

Enanta Pharmaceuticals (NASDAQ:ENTA) last released its earnings results on Monday, November 22nd. The biotechnology company reported ($1.22) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.31) by $0.09. Enanta Pharmaceuticals had a negative return on equity of 14.86% and a negative net margin of …

Category: Contact NumberShow more

Enanta Pharmaceuticals Reports Financial Results for its

4 hours ago Finance.yahoo.com Show details

WATERTOWN, Mass., November 22, 2021--Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2021

Category: Contact NumberShow more

Enanta Pharmaceuticals (ENTA) Reports Q4 Loss, Lags

8 hours ago Nasdaq.com Show details

Enanta Pharmaceuticals (ENTA) came out with a quarterly loss of $1.22 per share versus the Zacks Consensus Estimate of a loss of $1.31. This compares to loss of $0.55 per share a year ago. These

Category: Contact NumberShow more

Is Enanta Pharmaceuticals Inc (ENTA) Stock at the Top of

3 hours ago Investorsobserver.com Show details

Enanta Pharmaceuticals Inc is near the top in its industry group according to InvestorsObserver.ENTA gets an overall rating of 57. That means it scores higher than 57 percent of stocks. Enanta Pharmaceuticals Inc gets a 86 rank in the Biotechnology industry. Biotechnology is number 85 out of 148 industries.

Category: Contact NumberShow more

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) to Post FY2022

9 hours ago Marketbeat.com Show details

Enanta Pharmaceuticals has a 52 week low of $40.32 and a 52 week high of $86.10. A number of large investors have recently bought and sold shares of the business. Fisher Asset Management LLC lifted its position in shares of Enanta Pharmaceuticals by 4.1% in the second quarter.

Category: Contact NumberShow more

Where Enanta Pharmaceuticals Stands With Analysts Benzinga

5 hours ago Benzinga.com Show details

According to 5 analyst offering 12-month price targets in the last 3 months, Enanta Pharmaceuticals has an average price target of $65.4 with a high of $95.00 and a low of $50.00.

Category: Contact NumberShow more

Enanta Pharmaceuticals Reports Financial Results for its

2 hours ago Marketscreener.com Show details

WATERTOWN, Mass., November 22, 2021 - Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today reported financial results for its fiscal fourth quarter and year ended September 30, 2021.

Category: Contact NumberShow more

Enanta Pharmaceuticals Reaches Analyst Target Price Nasdaq

3 hours ago Nasdaq.com Show details

In recent trading, shares of Enanta Pharmaceuticals Inc (Symbol: ENTA) have crossed above the average analyst 12-month target price of $89.56, changing hands for $91.89/share. When a stock reaches

Category: Contact NumberShow more

Enanta Pharmaceuticals Reports Financial Results for its

7 hours ago Us.acrofan.com Show details

Enanta plans to issue its fiscal 2022 first quarter results press release, and hold a conference call regarding those results, on February 8, 2022. Conference Call and Webcast Information. Enanta will host a conference call and webcast today at 4:30 p.m. ET.

Category: Contact NumberShow more

Zacks Industry Outlook Highlights: Xencor, Enanta

6 hours ago Finance.yahoo.com Show details

1. Chicago, IL – October 28, 2021 – Today, Zacks Equity Research discusses Drugs, including Xencor XNCR, Enanta Pharmaceuticals ENTA, Catalyst Pharmaceuticals CPRX and Molecular Templates MTEM. Industry: Medical - Drugs Link: https://www.zacks.com/commentary/1817257/4-small-drug-stocks-that-hold-promise-despite-industry-challenges Sales of some drugs/vaccines/products are expected to have been hurt by business disruption due to COVID-19 in the third quarter despite an ongoing recovery from the earlier impacts of the pandemic. Though regulatory/pipeline updates related to COVID-19 medicines/vaccines have taken center stage this year as well, the sector has been witnessing developments in other innovative pipeline areas. Overall, successful innovation resulting in new drug/product approvals, important advances in clinical studies, and strategic collaborations with strong partners have kept companies like Xencor, Enanta Pharmaceuticals, Catalyst Pharmaceuticals and Molecular Templates afl...

Category: Contact NumberShow more

Annual Report (10k)

7 hours ago Ih.advfn.com Show details

ENTA Enanta Pharmaceuticals Inc Annual Report (10-k) Commission File Number 001-35839 . ENANTA PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware. 2834. The virus is transmitted through contact with the blood or other bodily fluids of an infected person. It is estimated that close to 300 million people

Category: Contact NumberShow more

Form 4 ENANTA PHARMACEUTICALS For: Nov 19 Filed by

9 hours ago Streetinsider.com Show details

Represents a grant of restricted stock units ("RSUs") under the Enanta Pharmaceuticals, Inc. ("Enanta") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon

Category: Contact NumberShow more

ENTA Enanta Pharmaceuticals Inc. Stock Price & News WSJ

3 hours ago Wsj.com Show details

View the latest Enanta Pharmaceuticals Inc. (ENTA) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Category: Contact NumberShow more

Enanta Pharmaceuticals Security Corporation in Watertown

7 hours ago Bizapedia.com Show details

Enanta Pharmaceuticals Security Corporation is a Massachusetts Domestic Profit Corporation filed On September 24, 2013. The company's File Number is listed as 001116991. The Registered Agent on file for this company is C T Corporation System and is located at 155 Federal Street, Suite 700, Boston, MA 02110.

Location: MA

Category: Contact NumberShow more

Expert Ratings For Enanta Pharmaceuticals Enanta

7 hours ago Benzinga.com Show details

According to 6 analyst offering 12-month price targets in the last 3 months, Enanta Pharmaceuticals has an average price target of $85.67 with a high of $121.00 and a low of $55.00. Below is a

Category: Contact NumberShow more

A 2 PART STUDY EVALUATING EDP721 IN HEALTHY SUBJECTS …

7 hours ago Clinicaltrials.gov Show details

Enanta Pharmaceuticals: ClinicalTrials.gov Identifier: NCT04971512 Other Study ID Numbers: EDP 721-001 : First Posted: July 21, 2021 Key Record Dates: Last Update Posted: August 20, 2021 Last Verified: August 2021

Category: Contact NumberShow more

2018 Annual Report

9 hours ago S22.q4cdn.com Show details

834 04-3205Commission File Number 001-35839 ENANTA PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) DELAWARE 2834 04-3205099 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 500 Arsenal Street Watertown, Massachusetts

Category: Contact NumberShow more

ENANTA PHARMACEUTICALS, INC. : ENTA Stock Price

3 hours ago Marketscreener.com Show details

Enanta Pharmaceuticals, Inc. is a biotechnology company. The Company uses chemistry-driven approach and drug discovery capabilities. The Company is focused on discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. The Company has clinical candidates for the disease targets, including

Category: Contact NumberShow more

ENTA: Enanta Pharmaceuticals Inc Stock Price, Quote and

2 hours ago Cnbc.com Show details

Enanta’s Q4 Loss Meets Expectations November 23, 2021 TipRanks Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA) and Paragon 28 (FNA) November 23, 2021 TipRanks Profile

Category: Contact NumberShow more

Enanta Pharmaceuticals, Inc. (ENTA) CEO Dr. Jay Luly on Q4

7 hours ago Seekingalpha.com Show details

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q4 2021 Earnings Conference Call November 22, 2021 04:30 AM ET Company Participants Dr.

Category: Contact NumberShow more

Enanta Pharmaceuticals Announces Data Presentations at

7 hours ago Marketwatch.com Show details

021-2021-10Press Release Enanta Pharmaceuticals Announces Data Presentations at AASLD’s The Liver Meeting® 2021 Published: Oct. 1, 2021 at 7:00 a.m. ET

Category: Contact NumberShow more

Enanta Pharmaceuticals Total Employees (Annual) ENTA

6 hours ago Ycharts.com Show details

Enanta Pharmaceuticals Presents New Data for EDP-235, its Lead Oral Protease Inhibitor Designed for the Treatment of COVID-19, at the ISIRV–WHO Virtual Conference 2021 Yahoo 10/19 07:00 ET Senior VP And Chief Medical Officer Of Enanta Pharmaceuticals Trades $2.0M In Company Stock

Category: Contact NumberShow more

Enanta Pharmaceuticals Funding, Financials, Valuation

1 hours ago Crunchbase.com Show details

Enanta Pharmaceuticals is an R&D company discovers, develops and promotes of small molecule drugs in the areas of anti-infective.

Category: Contact NumberShow more

After trial failure, Enanta narrows its focus to NASH

4 hours ago Biopharmadive.com Show details

While Enanta remains optimistic that its drug, EDP-305, could have a place in NASH treatment, results from the PBC study may be seen as foreboding. According to company management, the study results suffered from a higher-than …

Category: Contact NumberShow more

Enanta Pharmaceuticals Announces Data Presentations at

6 hours ago Businesswire.com Show details

617-744-3848Enanta Pharmaceuticals Announces Data Presentations at AASLD’s The Liver Meeting® 2021 Contacts Investor Contact Jennifer Viera 617-744-3848 [email protected]enanta.com

Category: Contact NumberShow more

Pfizer to seek authorization of COVID19 pill 'as soon as

2 hours ago Marketwatch.com Show details

Pfizer to seek authorization of COVID-19 pill ‘as soon as possible’ Last Updated: Nov. 9, 2021 at 9:00 a.m. ET First Published: Nov. 5, 2021 at 12:08 p.m. ET

Category: Contact NumberShow more

Why is Enanta Pharmaceuticals Inc. (ENTA) up 114.76% from

3 hours ago Investchronicle.com Show details

Enanta Pharmaceuticals Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $102.00 on 11/05/21, with the lowest value was $40.37 for the same time period, recorded on 07/15/21.

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Popular Brands

Essity
Engie
Eaton